31 August 2022>: Clinical Research
Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4–6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo
Blerim Myftiu 12ABCDEFG* , Zylfije Hundozi 12ACDF , Faton Sermaxhaj 3ABD , Afrim Blyta 1ACDF , Nexhmedin Shala 12CD , Fisnik Jashari 12C , Hasime Qorraj Bytyqi 4CDF , Ekrem Hyseni 3BC , Ilir Kurtishi 3BCDOI: 10.12659/MSM.937856
Med Sci Monit 2022; 28:e937856
Table 5 Motor nerve conduction studies.
Nerve | Parameter | Pre-treatment value (Mean±SD) | Post-treatment value (Mean±SD) | Significance |
---|---|---|---|---|
Median nerve (N: 119) | Distal latency (ms) | 3.2±0.6 | 3.7±0.8 | p |
Velocity (m/s) | 59.2±6.3 | 52.3±7.2 | p | |
Amplitude (mV) | 8.9±2.4 | 6.6±2.4 | p | |
Ulnar nerve (N: 119) | Distal latency (ms) | 2.6±0.4 | 2.8±0.5 | p |
Velocity (m/s) | 61.3±7.0 | 58.2±8.9 | p | |
Amplitude (mV) | 7.6±1.6 | 6.9±2.2 | p | |
Tibial nerve (N: 105) | Distal latency (ms) | 4.5±1.2 | 5.3±1.3 | p |
Velocity (m/s) | 46.0±5.5 | 41.6±5.1 | p | |
Amplitude (mV) | 8.1±3.3 | 5.1±3.4 | p | |
Peroneal nerve (N: 103) | Distal latency (ms) | 4.3±1.1 | 4.5±1.3 | p=0.515 |
Velocity (m/s) | 49.9±6.7 | 44.1±8.4 | p | |
Amplitude (mV) | 4.6±1.8 | 2.7±1.8 | p | |
SD – standard deviation. |